home / stock / pfe / pfe news


PFE News and Press, Pfizer Inc. From 06/20/24

Stock Information

Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com

Menu

PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...

PFE - From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data

2024-06-20 08:46:01 ET USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – This year’s 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without increasing hope for...

PFE - Key Takeaways from the 2024 ASCO Annual Meeting: Promising Developments in Cancer Care

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – This year’s 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without increasing hope for cancer patients around the w...

PFE - GeoVax stock rockets 50% on BARDA award for COVID-19 vaccine

2024-06-18 15:03:18 ET More on GeoVax GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on GeoVax Historical earnings data for GeoVax Financial information for GeoVax Read the full article on Seeking Alpha...

PFE - Pfizer sued in Kansas over COVID-19 vaccine

2024-06-18 14:13:37 ET More on Pfizer Pfizer Stock: The Reversal Should Keep Going Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcrip...

PFE - Day One in licensing pact with MabCare for cancer therapy

2024-06-18 13:13:38 ET More on Day One Biopharmaceuticals Day One Pharmaceuticals: Ojemda Approval A Big Win, Current Valuation Fair Day One Biopharmaceuticals announces sale of Priority Review Voucher for $108M Day One slips despite Ojemda approval as BofA says labe...

PFE - Ideaya Biosciences Continues Its Pursuit Of 'Synthetic Lethality'

2024-06-18 11:23:25 ET Summary The stock of Ideaya Biosciences, Inc. has risen some 50% since we last visited this clinical stage development firm focused on "synthetic lethality." The company continues to advance its pipeline, has partnerships with several Big Pharma names, and h...

PFE - Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb

2024-06-18 10:00:00 ET When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) . Both companies have a long history of paying dividends and offer...

PFE - Merck gets FDA approval for Capvaxive pneumonia vaccine (update)

2024-06-18 09:01:00 ET More on Merck Merck & Co., Inc. (MRK) Goldman Sachs 45th Annual Global Healthcare Conference - (Transcript) Dividends And Innovation: Why Merck Is A Healthcare Stock Worth Buying Merck & Co., Inc. (MRK) Investor Event at ASCO 2024 (Tran...

PFE - Pfizer stock price analysis: how PFE became a fallen angel

2024-06-18 07:03:33 ET Pfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 vaccines faded globally. It was trading at $28 on Monday, down from the pandemic high of $55.56. It has also underperformed the likes of Eli Lilly, Johnson & Johnson, ...

PFE - Pfizer Stock: The Reversal Should Keep Going

2024-06-18 05:56:25 ET Summary Pfizer's stock initially showed signs of recovery, but then stagnated while the rest of the market continued to grow. However, I expect a recovery in the medium term. The Company's Q1 results showed strong performance in non-COVID products and cost-s...

Previous 10 Next 10